Search Results For :: Advance Materials
-
Cardiac Monitoring & Rhythm Management Devices Market by Type [Cardiac Monitoring (ECG, Ambulatory Monitors), Cardiac Rhythm Management [Pacemaker (Single, Leadless), Defibrillator (AED)], Application [Arrhythmia], End User [Hospital] - Global Forecast to 2031
The global cardiac monitoring and cardiac rhythm management devices market, valued at USD 26.33 billion in 2025, stood at USD 27.90 billion in 2026 and is projected to advance at a resilient CAGR of 6.3% from 2026 to 2031, culminating in a forecasted valuation of USD 37.88 billion by the end of the period. The market is growing overall due to the rising prevalence of cardiovascular diseases and arrhythmias, driven largely by an aging global population and increasing lifestyle-related risk factors such as obesity and diabetes.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Global Machine Vision and Vision Guided Robotics Market (2010 - 2015)
The report reviews important developments in the markets for robotic vision hardware and software. It analyzes the market drivers, challenges and restraints in machine vision and 3D vision-guided robots in industrial automation and its applications.
- Published: May 2011
- Price: $ 4950
- TOC Available:
-
Global Service Robotics Market (2010 - 2015)
Robotics is a multi-disciplinary field covering almost all engineering and scientific areas. This report covers existing and emerging applications of robotics in manufacturing, homeland security, entertainment, learning, manufacturing, medical services and computer-assisted surgery. It will analyze the drivers, opportunities and restraints of robotics and provide market data for the applications, technologies and products.
- Published: July 2010
- Price: $ 4950
- TOC Available:
-
Renewable Chemicals Market (2010 - 2015)
Industrial biotechnology or white biotechnology uses cells and enzymes to produce bioenergy, biomaterials and other industrial products. The report will analyze the commercialization of the applications, technologies and products like renewable chemicals.
- Published: August 2009
- Price: $ 4950
- TOC Available:
-
Refinery Catalysts Market By Type (FCC Catalysts, Hydrotreating Catalysts, Hydrocracking Catalysts, Catalytic Reforming Catalysts), Ingredient (Zeolites, Metals, Chemical Compounds), and Region - Global Forecast to 2031
The refinery catalysts market is projected to grow from USD 6.20 billion in 2026 to USD 7.73 billion by 2031, at a CAGR of 4.5% during the forecast period. The key players include Albemarle Corporation (US), W. R. Grace (US), BASF (Germany), Haldor Topsoe (Denmark), Honeywell UOP (US), Clariant (Switzerland), Axens (France), Johnson Matthey (UK), China Petroleum and Chemical Corporation (Sinopec) (China), and Shell Catalyst & Technologies (Netherlands).
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Medical Membranes Market by Material (PSU, PES, PVDF, PTFE, PP, PAN, PA, Modified Acrylics), Process Technology (Ultrafiltration, Microfiltration, Nanofiltration), Application (Pharmaceutical Filtration, Hemodialysis, IV Fusion & Sterile Filtration, Membrane Oxygenator), and Region - Global Forecast to 2030
The medical membranes market is expected to grow from USD 4.31 billion in 2025 to USD 6.66 billion by 2030, at a compound annual growth rate (CAGR) of 9.1% during the forecast period. The Key Players Asahi Kasei Corporation (Japan), Mann+Hummel (Germany), Sartorius AG (Germany), Merck KGaA (Germany), Solventum (US), Cytiva (US), W. L. Gore & Associates, Inc. (US), Kovalus Separation Solutions (US), and Cobetter (China).
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Electroactive Polymer Market by Type (Conductive Plastic, Inherently Conductive Polymer, Inherently Dissipative Polymer), Application (ESD Protection, EMI Shielding, Actuators, Capacitors, Batteries, Sensors), and Region - Global Forecast to 2022
The electroactive polymers market was valued at USD 3.26 Billion in 2016 and is projected to reach USD 5.12 Billion by 2022, at a CAGR of 7.9% between 2017 and 2022. In this report, 2016 has been considered the base year and the forecast period has been considered from 2017 to 2022. These factors are propelling the demand for electroactive polymers in the region. Solvay (Belgium), Parker Hannifin (US) Agfa-Gevaert (Belgium), 3M (US), Merck (Germany), Lubrizol (US), Novasentis (US), Premix (Finland), and PolyOne Corporation (US), among others, are the key players operating in the electroactive polymers market.
- Published: February 2018
- Price: $ 4950
- TOC Available:
-
Dental Equipment Market (2009 - 2014)
The report provides market data on the latest and future equipment and technologies in the market. It also analyzes the key market trends, strategies of the key players and provides market data for the next five years. The focus is on the patented equipment and technologies being developed across the globe.
- Published: September 2009
- Price: $ 4950
- TOC Available:
-
Top 10 Drug Delivery Technologies Market (Topical, Oral Time Release/Sustained Release, Targeted Delivery, Encapsulation, Aerosol/Inhalation, Transdermal, Implants, Injectable, Liposomal, Pegylation) - Global Trends, Challenges & Forecasts up till 2015
This report provides industry analysis, competitive landscape and in-depth market segmentation for all the top 10 drug delivery technologies. It provides market data for the oral delivery system, which still dominates the drug delivery market. In addition, the report also analyzes the market data on emerging drug delivery technologies like needleless injectables, PEGylation technologies and microelectromechanical devices.
- Published: February 2011
- Price: $ 4950
- TOC Available:
-
Active Pharmaceutical Ingredients (API) Market by type (Innovative, Generic), Synthesis (synthetic, biotech), Potency (HPAPI), Product (mAbs, hormones), Drug (OTC, Rx), Application (Diabetes, Oncology), Competitive landscape - Global forecast to 2030
The global active pharmaceutical ingredient market, valued at US$136.22 billion in 2024, stood at US$144.20 billion in 2025 and is projected to advance at a resilient CAGR of 6.6% from 2024 to 2030, culminating in a forecasted valuation of US$198.39 billion by the end of the period. The growth of the active pharmaceutical ingredients market is driven by the surge in demand for complex APIs, such as high-potency API, peptides, oligonucleotides, and increasing government incentives and supply chain reshoring.
- Published: October 2025
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 60
